Literature DB >> 5787347

[1st clinical experience with a new oral antimycotic in systemic mycoses].

H Oberste-Lehn, I Baggesen, M Plempel.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5787347     DOI: 10.1055/s-0028-1111224

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  9 in total

Review 1.  Recent developments in antimycotic chemotherapy.

Authors:  R J Holt
Journal:  Infection       Date:  1974       Impact factor: 3.553

2.  Treatment of chronic mucocutaneous candidiasis of children (Candida Granuloma) with Clotrimazole.

Authors:  W Meinhof; D Günther
Journal:  Arch Dermatol Forsch       Date:  1972

3.  Pulmonary aspergillomata in a child treated with clotrimazole.

Authors:  E G Evans; D A Watson; N R Matthews
Journal:  Br Med J       Date:  1971-12-04

4.  A new synthetic antimycotic.

Authors: 
Journal:  Br Med J       Date:  1969-11-22

5.  Laboratory assessment of the antimycotic drug clotrimazole.

Authors:  R J Holt; R L Newman
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

6.  In vitro antifungal activity of clotrimazole (Bay b 5097).

Authors:  S Shadomy
Journal:  Infect Immun       Date:  1971-08       Impact factor: 3.441

7.  Chemotherapeutic evaluation of clotrimazole (Bay b 5097, 1 (o-chloro- - -diphenylbenzyl) imidazole).

Authors:  J A Waitz; E L Moss; M J Weinstein
Journal:  Appl Microbiol       Date:  1971-11

8.  Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies.

Authors:  M A Burgess; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

9.  Clotrimazole, an imidazole antimycotic, is a potent inhibitor of angiogenesis.

Authors:  H Takahashi; M Abe; T Sugawara; K Tanaka; Y Saito; S Fujimura; M Shibuya; Y Sato
Journal:  Jpn J Cancer Res       Date:  1998-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.